Avidity Biosciences
RNA
#1858
Rank
C$15.01 B
Marketcap
C$99.62
Share price
0.24%
Change (1 day)
111.80%
Change (1 year)

Avidity Biosciences (RNA) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNA) - since 2020

Volume in USD (price x number of shares), data since 2020

Avidity Biosciences (RNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025C$49.36 M206.29%
2024C$16.11 M267.16%
2023C$4.38 M-91.34%
2022C$50.7 M162.44%
2021C$19.31 M-77.68%
2020C$86.53 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
C$56.21 MC$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$48.95 MC$0.36 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$3.82 MC$21.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$10.3 MC$41.63 M๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.56 MC$1.36 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/AC$0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$0.27 MC$1.01 M๐Ÿ‡บ๐Ÿ‡ธ USA